Fluconazole Dosing Recommendations
For adults with normal renal function and invasive candidiasis, administer a loading dose of 800 mg (12 mg/kg), followed by 400 mg (6 mg/kg) daily. 1
Adult Dosing by Indication
Invasive Candidiasis/Candidemia
- Loading dose: 800 mg (12 mg/kg) on Day 1
- Maintenance: 400 mg (6 mg/kg) daily
- Duration: 14 days after first negative blood culture and resolution of symptoms 1
The IDSA guidelines from 2009 establish this as the standard fluconazole regimen for invasive disease, with strong evidence (A-I rating) supporting its efficacy comparable to amphotericin B deoxycholate 1.
Mucosal Candidiasis
- Oropharyngeal: 200 mg Day 1, then 100 mg daily for ≥14 days 2
- Esophageal: 400 mg daily for 14-21 days 2
- Vaginal (uncomplicated): 150 mg single dose 1
CNS and Intraocular Infections
Fluconazole achieves CSF concentrations of at least 50% of serum levels, making it the preferred triazole for CNS candidiasis 1. Use the same invasive candidiasis dosing (800 mg loading, then 400 mg daily).
Renal Impairment Dosing
For creatinine clearance <50 mL/min, reduce the maintenance dose by 50% after giving the full loading dose. 1, 3
Specific Adjustments:
- CrCl >50 mL/min: No adjustment needed (100% of standard dose)
- CrCl ≤50 mL/min (no dialysis): 50% of standard maintenance dose
- Hemodialysis: 100% of recommended dose after each dialysis session; on non-dialysis days, use 50% dose 3
The FDA label explicitly states that an initial loading dose of 50-400 mg should be given regardless of renal function, with subsequent doses adjusted based on creatinine clearance 3. This is critical because fluconazole is cleared primarily by renal excretion as unchanged drug 1, 3.
Important caveat: Recent pharmacokinetic studies demonstrate that patients on continuous renal replacement therapy (CRRT) require substantially higher doses—at least 400 mg twice daily—to achieve therapeutic targets 4. Standard renal dosing recommendations fail in CRRT patients due to significant drug removal by dialysis 5, 6.
Calculating Creatinine Clearance
When only serum creatinine is available 3:
- Males: [Weight (kg) × (140 - age)] / [72 × serum creatinine (mg/dL)]
- Females: 0.85 × male calculation
Pediatric Dosing
Pediatric patients require weight-based dosing with mg/kg doses approximately double those used in adults due to faster clearance. 7, 3
Standard Pediatric Regimens:
| Adult Dose | Pediatric Equivalent |
|---|---|
| 100 mg | 3 mg/kg |
| 200 mg | 6 mg/kg |
| 400 mg | 12 mg/kg* |
*Maximum 600 mg/day for older children 3
By Indication:
- Oropharyngeal candidiasis: 6 mg/kg Day 1, then 3 mg/kg daily for ≥14 days 3
- Esophageal candidiasis: 6 mg/kg Day 1, then 3 mg/kg daily (up to 12 mg/kg/day based on response) for ≥21 days 3
- Systemic Candida infections: 6-12 mg/kg/day 3
- Cryptococcal meningitis: 12 mg/kg Day 1, then 6 mg/kg daily (up to 12 mg/kg/day based on response) 3
Neonatal Dosing (Critical Age-Based Adjustments)
Neonates have prolonged elimination half-lives requiring extended dosing intervals. 3, 8
- Premature neonates (gestational age 26-29 weeks), first 2 weeks of life: Same mg/kg dose as older children, but administer every 72 hours
- Weeks 2-4 of life: Same dose every 48 hours
- After 4 weeks: Daily dosing appropriate 3, 8
The recommended daily dose for neonates is 6 mg/kg, with therapeutic drug monitoring advised to maintain plasma concentrations between 4-20 mcg/mL 8.
Pediatric Renal Impairment
Dosage reduction should parallel adult recommendations, though pharmacokinetic data in children with renal insufficiency are limited 3. Estimate creatinine clearance using 3:
CrCl = [K × height (cm)] / serum creatinine (mg/dL)
- K = 0.55 for children >1 year
- K = 0.45 for infants
Key Pharmacokinetic Properties
Fluconazole demonstrates ~90% oral bioavailability, allowing interchangeable use of oral and IV formulations 1. Absorption is unaffected by food, gastric pH, or disease state 1. The drug achieves:
- Urine concentrations 10-20× serum levels 1
- CSF concentrations ≥50% of serum 1
- Minimal protein binding (11%) 9
- Long half-life (22-32 hours in normal renal function) 9
Critical Pitfalls
CRRT patients: Standard renal dosing is inadequate. Recent evidence shows at least 400 mg twice daily is needed for target attainment 4. Fluconazole clearance can increase 2.5-fold with CVVHDF 6.
Loading dose omission: Failing to give the full loading dose (regardless of renal function) delays achievement of therapeutic concentrations 3.
Neonatal dosing errors: Using daily dosing in premature neonates <2 weeks old leads to drug accumulation due to prolonged half-life 3, 8.
Drug interactions: All azoles inhibit cytochrome P450 enzymes. Monitor closely when co-administering with cyclosporine, phenytoin, warfarin, oral hypoglycemics, or rifampin 1.
Species-specific considerations: Fluconazole has reduced activity against C. glabrata and C. krusei. For C. glabrata, echinocandins are preferred 1. For C. parapsilosis, fluconazole is preferred over echinocandins 1.